Russian pharmaceutical company Cytomed to start exports from Finland

Pharmaceutical products made in Finland enjoy a good reputation in the Russian market.

According to Julia Volkov, Cytomed’s CEO in Finland, exports to the Russian market can start in Spring 2015. She believes that the export opportunities to Russia are still there despite the recent fluctuations in the value of the Russian ruble.


“We hope, however, that the fluctuations affecting ruble will come to an end. This would provide us and our Russian customers the opportunity for more long-term planning,” says Volkov in an interview with Yle.

Sources: Yle, Cytomed